Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527, Athens, Greece.
Department of Internal Medicine, Metropolitan Hospital, 9 Ethnarchou Makariou Street, 18547, Athens, Greece.
Antimicrob Resist Infect Control. 2020 Dec 1;9(1):189. doi: 10.1186/s13756-020-00851-1.
Placement of central-venous catheters (CVCs) is an essential practice in the management of hospitalized patients, however, insertion at the commonly used sites has often the potential of inducing major complications. Neverthelss, the impact of specific site central line catheter insertion on catheter-associated bloodstream infections (CLABSIs) has not been clarified yet in the literature.
The aim of the study was to compare CLABSIs and catheter colonization rates among the three catheter insertion sites: subclavian (SC), internal jugular (IJ) and femoral (FEM) in hospitalized patients. Moreover, to analyze the distribution of pathogens and their antimicrobial resistance profiles at these three sites, concurrently.
We performed a retrospective analysis of data collected prospectively from all catheterized patients at a tertiary care Greek hospital from May 2016 to May 2018. Data was collected on 1414 CVCs and 13,054 CVC-days.
Τhe incidence of CLABSIs among the three sites was as follows: SC:5.1/1000 catheter/days, IJ: 3.73/1000 catheter/days and FEM: 6.93/1000 catheter/days (p = 0.37). The incidence of colonization was as follows: SC:13.39/1000 catheter/days; IJ:7.34/ 1000 catheter/days; FEM:22.91/1000 catheter/days (p = 0.009). MDROs predominated in both CLABSIs and tip colonizations (59.3 and 61%, respectively) with Acinetobacter baumanii being the predominant pathogen (16/59, 27.1% and 44/144, 30.5%, respectively). The incidence of CLABSIs due to multidrug-resistant organisms (MDROs) was as follows: SC:3.83/1000 catheter days; IJ:1.49/1000 catheter days; FEM:5.86/1000 catheter days (p = 0.04). The incidence of tip colonization by MDROs among the 3 sites was as follows: SC:8.93/1000 catheter/days; IJ:4.48/1000 catheter/days; FEM:12.79/1000 catheter/days (p = 0.06). There was no significant difference in the type of pathogen isolated among site groups for both CLABSIs and tip colonizations.
FEM site of catheter insertion was associated with a higher rate of bloodstream infection and catheters' colonization compared to IJ and SC sites. Furthermore, this survey highlights the changing trend of the distribution of frequent pathogens and resistance patterns towards MDR Gram-negative pathogens, underscoring the need for consistent monitoring of antimicrobial resistance patterns of these specific infections.
中心静脉导管(CVC)的置管是住院患者管理中的一项重要操作,但在常用置管部位进行置管时,常常存在引发严重并发症的风险。然而,文献中尚未阐明特定部位的中心静脉导管置管对导管相关性血流感染(CLABSIs)的影响。
本研究旨在比较锁骨下(SC)、颈内(IJ)和股静脉(FEM)三种导管插入部位的 CLABSIs 和导管定植率,并同时分析这三个部位的病原体分布及其对抗菌药物的耐药谱。
我们对 2016 年 5 月至 2018 年 5 月在希腊一家三级护理医院接受置管的所有患者前瞻性收集的数据进行了回顾性分析。共收集了 1414 例 CVC 和 13054 例 CVC 日的数据。
三个部位的 CLABSIs 发生率如下:SC:5.1/1000 导管/天;IJ:3.73/1000 导管/天;FEM:6.93/1000 导管/天(p=0.37)。定植率如下:SC:13.39/1000 导管/天;IJ:7.34/1000 导管/天;FEM:22.91/1000 导管/天(p=0.009)。耐多药菌(MDROs)在 CLABSIs 和尖端定植中均占主导地位(分别为 59.3%和 61%),其中鲍曼不动杆菌是主要病原体(分别为 16/59,27.1%和 44/144,30.5%)。CLABSIs 由 MDROs 引起的发生率如下:SC:3.83/1000 导管天;IJ:1.49/1000 导管天;FEM:5.86/1000 导管天(p=0.04)。3 个部位的 MDROs 尖端定植率如下:SC:8.93/1000 导管/天;IJ:4.48/1000 导管/天;FEM:12.79/1000 导管/天(p=0.06)。在 CLABSIs 和尖端定植中,不同部位的病原体分离类型没有显著差异。
与 IJ 和 SC 部位相比,FEM 部位的导管插入与血流感染和导管定植的发生率更高。此外,本研究强调了常见病原体的分布趋势和对 MDR 革兰氏阴性病原体的耐药模式的变化,突出了对这些特定感染的抗菌药物耐药模式进行持续监测的必要性。